Trial Profile
Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2015 New trial record